176 related articles for article (PubMed ID: 26840933)
1. [Porphyria cutanea tarda: the benefit of additional diagnostics].
Vossen AR; Boesten LS; Siersema PD; Nellen RG
Ned Tijdschr Geneeskd; 2016; 160():A9166. PubMed ID: 26840933
[TBL] [Abstract][Full Text] [Related]
2. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
3. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
5. Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature.
Young LC
Cutis; 2007 Nov; 80(5):415-8. PubMed ID: 18189029
[TBL] [Abstract][Full Text] [Related]
6. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
8. Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C.
Azim J; McCurdy H; Moseley RH
World J Gastroenterol; 2008 Oct; 14(38):5913-5. PubMed ID: 18855993
[TBL] [Abstract][Full Text] [Related]
9. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
Bygum A; Christiansen L; Petersen NE; Hørder M; Thomsen K; Brandrup F
Acta Derm Venereol; 2003; 83(2):115-20. PubMed ID: 12735639
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C, porphyria cutanea tarda and liver iron: an update.
Ryan Caballes F; Sendi H; Bonkovsky HL
Liver Int; 2012 Jul; 32(6):880-93. PubMed ID: 22510500
[TBL] [Abstract][Full Text] [Related]
11. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
[TBL] [Abstract][Full Text] [Related]
12. Iron overload in porphyria cutanea tarda.
Sampietro M; Fiorelli G; Fargion S
Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
[TBL] [Abstract][Full Text] [Related]
13. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
[TBL] [Abstract][Full Text] [Related]
14. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
[TBL] [Abstract][Full Text] [Related]
15. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic.
Kratka K; Dostalikova-Cimburova M; Michalikova H; Stransky J; Vranova J; Horak J
Br J Dermatol; 2008 Sep; 159(3):585-90. PubMed ID: 18565178
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
Wolff CF; Armas RM; Frank J; Poblete PG
Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
[TBL] [Abstract][Full Text] [Related]
18. An unhappy triad: hemochromatosis, porphyria cutanea tarda and hepatocellular carcinoma-a case report.
Mogl MT; Pascher A; Presser SJ; Schwabe M; Neuhaus P; Nuessler NC
World J Gastroenterol; 2007 Apr; 13(13):1998-2001. PubMed ID: 17461505
[TBL] [Abstract][Full Text] [Related]
19. Porphyria cutanea tarda: Recent update.
Singal AK
Mol Genet Metab; 2019 Nov; 128(3):271-281. PubMed ID: 30683557
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.
Roberts AG; Whatley SD; Morgan RR; Worwood M; Elder GH
Lancet; 1997 Feb; 349(9048):321-3. PubMed ID: 9024376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
